Suppr超能文献

补体在免疫和炎症性疾病中的作用:病理生理机制。

Complement in immune and inflammatory disorders: pathophysiological mechanisms.

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

J Immunol. 2013 Apr 15;190(8):3831-8. doi: 10.4049/jimmunol.1203487.

Abstract

Although acute or chronic inflammation is a common component of many clinical disorders, the underlying processes can be highly distinct. In recent years, the complement system has been associated with a growing number of immunological and inflammatory conditions that include degenerative diseases, cancer, and transplant rejection. It becomes evident that excessive activation or insufficient control of complement activation on host cells can cause an immune imbalance that may fuel a vicious cycle between complement, inflammatory cells, and tissue damage that exacerbates clinical complications. Although the exact involvement of complement needs to be carefully investigated for each disease, therapeutic modulation of complement activity emerges as an attractive target for upstream inhibition of inflammatory processes. This review provides an update about the functional and collaborative capabilities of complement, highlights major disease areas with known complement contribution, and indicates the potential for complement as a focal point in immunomodulatory strategies for treating inflammatory diseases.

摘要

虽然急性或慢性炎症是许多临床疾病的常见组成部分,但潜在的过程可能高度不同。近年来,补体系统与越来越多的免疫和炎症性疾病相关联,包括退行性疾病、癌症和移植排斥。很明显,补体对宿主细胞的过度激活或控制不足会导致免疫失衡,从而加剧补体、炎症细胞和组织损伤之间的恶性循环,加重临床并发症。尽管需要仔细研究每种疾病中补体的确切参与,但补体活性的治疗调节作为炎症过程上游抑制的有吸引力的靶点出现。本文综述了补体的功能和协同作用能力,强调了已知补体参与的主要疾病领域,并指出补体作为治疗炎症性疾病的免疫调节策略的焦点的潜力。

相似文献

1
Complement in immune and inflammatory disorders: pathophysiological mechanisms.
J Immunol. 2013 Apr 15;190(8):3831-8. doi: 10.4049/jimmunol.1203487.
2
Novel mechanisms and functions of complement.
Nat Immunol. 2017 Nov 16;18(12):1288-1298. doi: 10.1038/ni.3858.
4
A regulatory role for complement in innate immunity and autoimmunity.
Int Arch Allergy Immunol. 2004 Aug;134(4):310-23. doi: 10.1159/000079261. Epub 2004 Jun 23.
5
Complement in immune and inflammatory disorders: therapeutic interventions.
J Immunol. 2013 Apr 15;190(8):3839-47. doi: 10.4049/jimmunol.1203200.
6
The role of the complement system and the activation fragment C5a in the central nervous system.
Neuromolecular Med. 2010 Jun;12(2):179-92. doi: 10.1007/s12017-009-8085-y. Epub 2009 Sep 11.
7
Complement: an overview for the clinician.
Hematol Oncol Clin North Am. 2015 Jun;29(3):409-27. doi: 10.1016/j.hoc.2015.02.001. Epub 2015 Apr 4.
8
Complement in the immunopathogenesis of rheumatic disease.
Nat Rev Rheumatol. 2012 Aug;8(8):458-68. doi: 10.1038/nrrheum.2012.75. Epub 2012 Jun 5.
9
The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.
Clin Rev Allergy Immunol. 2020 Apr;58(2):229-251. doi: 10.1007/s12016-019-08774-5.
10
Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads.
Front Immunol. 2019 Oct 1;10:2306. doi: 10.3389/fimmu.2019.02306. eCollection 2019.

引用本文的文献

2
Multiscale information processing in the immune system.
Front Immunol. 2025 Jul 21;16:1563992. doi: 10.3389/fimmu.2025.1563992. eCollection 2025.
4
The new perspective on understanding the mechanisms of cardiovascular diseases development.
Sci Rep. 2025 Jul 22;15(1):26596. doi: 10.1038/s41598-025-11345-8.
6
Impact of smoking on the complement system: a narrative review.
Front Immunol. 2025 Jun 19;16:1619835. doi: 10.3389/fimmu.2025.1619835. eCollection 2025.
7
Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases.
J R Soc Interface. 2025 Jul;22(228):20250138. doi: 10.1098/rsif.2025.0138. Epub 2025 Jul 2.

本文引用的文献

1
Complement in immune and inflammatory disorders: therapeutic interventions.
J Immunol. 2013 Apr 15;190(8):3839-47. doi: 10.4049/jimmunol.1203200.
3
Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonist.
J Immunol. 2012 Dec 1;189(11):5442-8. doi: 10.4049/jimmunol.1202339. Epub 2012 Oct 22.
4
The inflammatory response in sepsis.
Trends Immunol. 2013 Mar;34(3):129-36. doi: 10.1016/j.it.2012.09.004. Epub 2012 Oct 2.
5
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.
J Immunol. 2012 Nov 1;189(9):4674-83. doi: 10.4049/jimmunol.1201654. Epub 2012 Oct 1.
6
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.
Nat Rev Nephrol. 2012 Nov;8(11):643-57. doi: 10.1038/nrneph.2012.214. Epub 2012 Oct 2.
7
Progress and Trends in Complement Therapeutics.
Adv Exp Med Biol. 2013;735:1-22. doi: 10.1007/978-1-4614-4118-2_1.
8
STEC-HUS, atypical HUS and TTP are all diseases of complement activation.
Nat Rev Nephrol. 2012 Nov;8(11):622-33. doi: 10.1038/nrneph.2012.195. Epub 2012 Sep 18.
9
Interactions of the humoral pattern recognition molecule PTX3 with the complement system.
Immunobiology. 2012 Nov;217(11):1122-8. doi: 10.1016/j.imbio.2012.07.004.
10
Complement and dysbiosis in periodontal disease.
Immunobiology. 2012 Nov;217(11):1111-6. doi: 10.1016/j.imbio.2012.07.007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验